NetraMark Holdings Inc

NetraMark Holdings uses explainable AI to revolutionize psychiatric clinical trials—enhancing patient stratification and predictive enrichment for precision psychiatry.

NetraMark Holdings Inc., a Canadian company listed on the Canadian National Stock Exchange, has experienced significant market fluctuations, with its current close price at CAD 1.27, highlighting the company’s volatility and dynamic market condition…

NetraMark Holdings Inc. is a Canadian company navigating market fluctuations, with a mixed financial picture and potential for growth, making it a high-risk, high-reward investment opportunity.